McArdle disease: molecular genetic update

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• McArdle disease (Glycogenosis type V) is an autosomal recessive metabolic disorder.
• It results from a deficiency in the muscle isoform of glycogen phosphorylase (myophosphorylase, PYGM).
• PYGM is the key enzyme initiating glycogen breakdown in skeletal muscle.

Purpose of the Study:

• To summarize the current understanding of McArdle disease.
• To highlight advances in the molecular genetics of the condition.
• To document the genetic heterogeneity observed in the PYGM gene.

Main Methods:

• Literature review of clinical and genetic studies on McArdle disease.
• Analysis of identified mutations in the PYGM gene.
• Review of historical clinical descriptions and recent genetic findings.

Main Results:

• McArdle disease is caused by PYGM deficiency, impacting skeletal muscle glycogenolysis.
• Worldwide patient identification and significant research have advanced disease understanding.
• Over 65 distinct mutations in the PYGM gene have been identified to date.

Conclusions:

• McArdle disease exhibits significant molecular heterogeneity.
• Genetic research has identified numerous PYGM gene mutations.
• Continued study is crucial for understanding and potentially treating this metabolic disorder.